ARGIMAG, CARDIOLOGIC DRUG

摘要

The cardiologic drug consists of L-arginine-related component and the pharmacologically active additive. L-arginine or L-arginine hydrochloride is used as L-arginine-related component. Magnesium-containing substance, namely magnesium oxide, magnesium carbonate basic, magnesium gluconate, magnesium citrate or magnesium aspartate, is used as the pharmacologically active additive. The following molar content of the substances is selected for the composition: 0.25-0.55 mol of L-arginine and 0.15-0.45 mol of magnesium substance.